As of 2025-05-04, the Intrinsic Value of Chemometec A/S (CHEMM.CO) is 275.35 DKK. This CHEMM.CO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 486.80 DKK, the upside of Chemometec A/S is -43.40%.
The range of the Intrinsic Value is 170.79 - 923.27 DKK
Based on its market price of 486.80 DKK and our intrinsic valuation, Chemometec A/S (CHEMM.CO) is overvalued by 43.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 170.79 - 923.27 | 275.35 | -43.4% |
| DCF (Growth 10y) | 226.50 - 1,213.34 | 364.53 | -25.1% |
| DCF (EBITDA 5y) | 184.73 - 319.52 | 249.05 | -48.8% |
| DCF (EBITDA 10y) | 233.47 - 428.48 | 320.70 | -34.1% |
| Fair Value | 242.93 - 242.93 | 242.93 | -50.10% |
| P/E | 280.54 - 359.93 | 306.82 | -37.0% |
| EV/EBITDA | 135.77 - 251.92 | 182.68 | -62.5% |
| EPV | 112.98 - 172.43 | 142.71 | -70.7% |
| DDM - Stable | 106.87 - 850.71 | 478.79 | -1.6% |
| DDM - Multi | 166.87 - 1,003.31 | 283.30 | -41.8% |
| Market Cap (mil) | 8,470.32 |
| Beta | 0.40 |
| Outstanding shares (mil) | 17.40 |
| Enterprise Value (mil) | 8,213.36 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.20% |
| Cost of Debt | 17.39% |
| WACC | 7.20% |